BlackRock, Inc.

Position in RVMD — Revolution Medicines, Inc.

CIK 2012383 New York, NY

Position in RVMD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,564,947,540

+$1,474,511,891 QoQ

Shares Held

13,695,790

+22.1% QoQ

Ownership

6.39%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 685 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. RVMD ranks #4 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc. This page	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,564,947,540	13,695,790	+22.1%	Shares	Sole	2026-08-07
2026-06-30	$2,285,077,255	12,201,395	—	Shares	Sole	2026-07-29
2026-03-31	$1,090,435,649	11,212,706	+25.6%	Shares	Sole	2026-05-13
2025-12-31	$711,008,139	8,926,656	+7.2%	Shares	Sole	2026-02-12
2025-09-30	$388,906,290	8,327,758	-3.9%	Shares	Sole	2025-11-12
2025-06-30	$318,652,641	8,661,393	-41.0%	Shares	Sole	2025-08-12
2025-03-31	$519,522,974	14,692,392	-0.2%	Shares	Sole	2025-05-02
2024-12-31	$643,833,021	14,719,548	+6.1%	Shares	Sole	2025-02-07
2024-09-30	$628,862,001	13,866,858	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.